Based on these observations, de Giorgi and coworkers suggested that cutaneous melanoma should be considered as a hormone-related tumor (76), although this conclusion is mainly supported by the results from the studies analyzing the estrogen receptor (ER), particularly the ERβ, status of melanomas. This evidence concerns the gene ESR1 and cutaneous melanoma.